Asunto(s)
Humanos , Femenino , Anciano , Remisión Espontánea , Enfermedad de Hodgkin/rehabilitación , Linfoma Folicular , COVID-19RESUMEN
BACKGROUND: Hodgkin lymphoma (HL) is a leading cancer diagnosis for adolescents and young adults (AYAs), with an overall 5-year survival rate of >80%. However, to the authors' knowledge, little is known regarding posttreatment patterns of care. In the current study, the authors characterized the use of guideline-recommended services in a cohort of AYA survivors of HL in Kaiser Permanente Southern California. METHODS: Patients with HL who were diagnosed between ages 15 and 39 years between 2000 and 2010 were identified. The authors calculated the number of patients who received recommended short-term care within 2 years after treatment cessation for those who remained enrolled and alive from 2001 through 2015. Use of recommended late-effects screening for breast cancer and cardiovascular disease was examined. Logistic regression was used to evaluate the association between receipt of recommended care and patient, cancer, and treatment characteristics. RESULTS: A total of 354 patients were identified, with a mean age at the time of diagnosis of 26 years (standard deviation, 6.9 years). Approximately 12% of patients had stage I disease, 59% had stage II disease, 17% had stage III disease, and 13% of patients had stage IV disease. Nearly all patients received chemotherapy (95%), 51% received radiotherapy, and 5% received care from a pediatric oncologist. Overall, approximately 49% of patients received recommended short-term care. Of those patients eligible for cardiovascular screening at 10 years posttreatment (60 patients), 53% received at least 1 screening. Of those patients eligible for breast cancer screening (21 patients), approximately 50% underwent at least 1 screening. Regression results indicated that those patients treated by a pediatric oncologist were >3 times as likely to receive recommended short-term care. CONCLUSIONS: The results of the current study highlight gaps in the delivery of posttreatment care to AYA survivors of HL. By determining areas in need of improvement, these findings can guide the development of tailored interventions with which to improve care.
Asunto(s)
Atención Ambulatoria , Supervivientes de Cáncer/estadística & datos numéricos , Enfermedad de Hodgkin/epidemiología , Enfermedad de Hodgkin/rehabilitación , Aceptación de la Atención de Salud/estadística & datos numéricos , Cooperación del Paciente/estadística & datos numéricos , Adolescente , Adulto , Atención Ambulatoria/normas , Atención Ambulatoria/estadística & datos numéricos , Atención a la Salud/estadística & datos numéricos , Femenino , Enfermedad de Hodgkin/psicología , Humanos , Masculino , Participación del Paciente/estadística & datos numéricos , Supervivencia , Adulto JovenRESUMEN
Cancer survivors often experience poor post-treatment musculoskeletal health. This study examined the feasibility of combined aerobic and resistant training (CART) for improving strength, skeletal health and balance. Cancer survivors (n = 24) were identified by convenience sampling in Los Angeles County with 11 survivors consenting to 13 weeks of CART. Pre- and post-intervention assessments of bone mineral density (BMD), strength, flexibility and biomarker analysis were performed. Paired t-test analysis suggested increases in lower and upper body strength. The average T-score for BMD at the femoral neck improved from -1.46 to -1.36 and whole body BMD improved from -1.65 to -1.55. From baseline to follow-up, participants also displayed decreases in sway velocity on the eyes open (7%) and eyes closed (27%) conditions. Improvement in lower body strength was associated with increases in lean body mass (LBM) (r = 0.721) and an inverse association was observed between sway velocity and LBM (r = 0.838). Age and time since last treatment were related with biomarkers of anabolic growth (IGF-1, IGFbp-3) and bone (DPD, BAP). In summary, observed physiological changes were consistent with functional improvements, suggesting that isometric and dynamic exercise prescription may reduce the risk for falls and fall-related fractures among survivors.
Asunto(s)
Densidad Ósea , Terapia por Ejercicio/métodos , Fuerza Muscular , Neoplasias/rehabilitación , Equilibrio Postural , Rango del Movimiento Articular , Entrenamiento de Fuerza , Sobrevivientes , Absorciometría de Fotón , Accidentes por Caídas/prevención & control , Adulto , Anciano , Biomarcadores/metabolismo , Neoplasias de la Mama/rehabilitación , Neoplasias del Colon/rehabilitación , Ejercicio Físico , Estudios de Factibilidad , Femenino , Enfermedad de Hodgkin/rehabilitación , Humanos , Proteína 3 de Unión a Factor de Crecimiento Similar a la Insulina/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Persona de Mediana Edad , Neoplasias Ováricas/rehabilitación , Proyectos Piloto , Estudios ProspectivosRESUMEN
OBJECTIVE: Adherence to rehabilitation exercise is much lower in patients with hematologic malignancies (22.5-45.8%) than in patients with solid tumors (60-85%) due to the administration of more intensive chemotherapeutic regimens in the former. Virtual reality exercise can be performed even in a biological clean room and it may improve the adherence rates in elderly patients with hematologic malignancies. Thus, in this pilot study, we aimed to investigate the feasibility and safety of virtual reality exercise intervention using Nintendo Wii Fit in patients with hematologic malignancies receiving chemotherapy. METHODS: In this feasibility study, 16 hospitalized patients with hematologic malignancies aged ≥60 years performed virtual reality exercise for 20 minutes using the Nintendo Wii Fit once a day, five times a week, from the start of chemotherapy until hospital discharge. The adherence rate, safety, and physical and psychological performances were assessed. RESULTS: The adherence rate for all 16 patients was 66.5%. Nine patients completed the virtual reality exercise intervention with 88 sessions, and the adherence rate was 62.0%. No intervention-related adverse effects >Grade 2, according to National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0, were observed. We noted maintenance of the physical performance (e.g., Barthel index, handgrip strength, knee extension strength, one-leg standing time, and the scores of timed up and go test and Instrumental Activities of Daily Living) and psychosocial performance (e.g., score of hospital anxiety and depression scale). CONCLUSION: Virtual reality exercise using the Wii Fit may be feasible, safe and efficacious, as demonstrated in our preliminary results, for patients with hematologic malignancies receiving chemotherapy.
Asunto(s)
Enfermedad de Hodgkin/rehabilitación , Leucemia/rehabilitación , Linfoma no Hodgkin/rehabilitación , Terapia de Exposición Mediante Realidad Virtual , Actividades Cotidianas , Anciano , Terapia por Ejercicio/métodos , Estudios de Factibilidad , Femenino , Enfermedad de Hodgkin/psicología , Humanos , Leucemia/psicología , Linfoma no Hodgkin/psicología , Masculino , Persona de Mediana Edad , Selección de Paciente , Modalidades de Fisioterapia , Estudios Prospectivos , Resultado del Tratamiento , Juegos de Video , Terapia de Exposición Mediante Realidad Virtual/métodosRESUMEN
The issue of taking into consideration future fertility in young women with breast cancer and Hodgkin's lymphoma [HL] will become more and more common and represent a growing clinical challenge for gynecologists and oncologists. The present paper will review literature data on the attempts of preventing chemotherapy-induced ovarian damage in these women and on their fertility outcome. Gonadotropin-releasing hormone [Gn-RH] agonists have been widely investigated as agents able to prevent ovarian failure in animal models and in humans. The majority of the studies on women with breast cancer and HL have shown a protective effect of Gn-RH agonists. A recent meta-analysis of five randomized trials, including 528 premenopausal breast cancer patients, revealed that relative risk [RR] of developing premature ovarian failure within one year was 0.40 (95% confidence interval [CI] = 0.21-0.75) for the women who received Gn-RH agonists with chemotherapy compared to those who received chemotherapy alone. However, the concurrent administration of Gn-RH agonists during chemotherapy appeared to have no effect on spontaneous pregnancy rates. Limited information are available about pregnancies in breast cancer and HL survivors, but the current literature appears to show no apparent increase in pregnancy complications, spontaneous abortions, or congenital abnormalities compared to general obstetric population.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Preservación de la Fertilidad , Enfermedad de Hodgkin/tratamiento farmacológico , Complicaciones Neoplásicas del Embarazo/fisiopatología , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/rehabilitación , Femenino , Ginecología , Enfermedad de Hodgkin/epidemiología , Enfermedad de Hodgkin/rehabilitación , Humanos , Oncología Médica , Embarazo , Sobrevivientes , Resultado del Tratamiento , Recursos HumanosRESUMEN
Cancer survivors are at risk of experiencing adverse physical and psychosocial effects of their cancer and its treatment. Both Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) survivors face problems that can affect their health-related quality of life (HRQoL). The authors systematically reviewed the literature on HRQoL among HL and NHL survivors. A PubMed and PsychINFO literature search for original articles published until May 2011 was performed. Twenty-four articles, which met the predefined inclusion criteria, were subjected to a quality checklist. HL survivors showed the most problems in (role) physical, social and cognitive functioning, general health, fatigue and financial problems. In addition, HL survivors treated with a combination of therapies, with older age and female sex reported worse HRQoL. NHL survivors showed the most problems in physical functioning, appetite loss, vitality and financial problems. Having had chemotherapy was negatively associated with HRQoL, but no differences in chemotherapy regimens were found. Furthermore, in NHL survivors not meeting public exercise guidelines, HRQoL is low but can be improved with more exercise. More research on the longitudinal comparison between HL and NHL survivors and healthy controls should be performed in order to better understand the long-term (side) effects of treatment on HRQoL and possibilities to alleviate these.
Asunto(s)
Indicadores de Salud , Enfermedad de Hodgkin/terapia , Linfoma no Hodgkin/terapia , Calidad de Vida , Sobrevivientes , Algoritmos , Femenino , Salud , Enfermedad de Hodgkin/epidemiología , Enfermedad de Hodgkin/psicología , Enfermedad de Hodgkin/rehabilitación , Humanos , Linfoma no Hodgkin/epidemiología , Linfoma no Hodgkin/psicología , Linfoma no Hodgkin/rehabilitación , Masculino , Factores Socioeconómicos , Sobrevivientes/psicología , Sobrevivientes/estadística & datos numéricos , Resultado del TratamientoRESUMEN
In this study, we investigated the quality of life (QoL) of long-term survivors with Hodgkin lymphoma who received high-dose chemotherapy (HDCT) followed by peripheral blood stem cell transplantation (PBSCT). QoL of this group was compared with QoL of patients who were treated with conventional chemotherapy and with QoL of the healthy German population. Two standardized questionnaires, the EORTC QLQ-C30 and the EQ-5D, including the visual analogue scale (VAS) were applied. A total of 98 patients were included in the study, all of them treated in our institution. Thirty-seven patients who received HDCT with PBSCT between 1986 and 2007 were compared with 61 patients treated with conventional chemotherapy and supplementary radiation between 1998 and 2009. The median follow-up for the HDCT group was 11 years. Statistical analysis with the one-sample t-test shows a reduced QoL of both groups of patients compared to the healthy population. Compared to the group of patients who received conventional chemotherapy, there is a tendency towards reduced QoL in patients with HDCT in all of the three main categories of the EORTC-QLQ-C30. However, these differences were not statistically significant, with the exception of the subcategory of dyspnoea, which was worse in the group that was treated with BCNU containing high-dose protocols. We conclude that the negative impact of both HDCT and conventional therapy on the QoL of long-term survivors with Hodgkin lymphoma should not be underestimated and should lead to the development of less toxic therapy strategies.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Trasplante de Células Madre Hematopoyéticas/métodos , Enfermedad de Hodgkin/terapia , Calidad de Vida , Sobrevivientes , Adulto , Anciano , Terapia Combinada , Relación Dosis-Respuesta a Droga , Femenino , Estudios de Seguimiento , Enfermedad de Hodgkin/psicología , Enfermedad de Hodgkin/rehabilitación , Humanos , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios , Sobrevivientes/psicología , Trasplante Autólogo , Adulto JovenRESUMEN
BACKGROUND: The aim of this study was to investigate the long-term side effects of treatment for childhood Hodgkin's lymphoma with chemotherapy only on growth, bone mineral density (BMD), body composition, and thyroid function. PROCEDURE: A total of 88 patients (56 male, 32 female; 17.6-42.6 yr), treated for childhood Hodgkin's lymphoma from 1974-1998 with combination chemotherapy adriamycin (doxorubicin), bleomycin, vinblastine, and dacarbazine or epirubicin, bleomycin, vinblastine, dacarbazine with or without mechlorethamine, oncovin (vincristine), procarbazine, and prednisone (MOPP) with the intention to avoid radiotherapy, participated in this study. Median follow-up was 15.5 yr (range 5.6-30.2). BMD of lumbar spine and total body (BMD-TB), and body composition were measured using dual-energy x-ray absorptiometry. Bone mineral apparent density of the lumbar spine was calculated to correct for bone size. Free T4 and TSH were measured. RESULTS: Men treated with MOPP had a significantly reduced height with normal body proportions. Women treated with MOPP had decreased BMD-TB and bone mineral apparent density of the lumbar spine as compared with healthy controls. Percent body fat was significantly increased in female patients treated without MOPP. Body mass index was significantly increased in male patients treated without MOPP, whereas lean body mass was normal in all patients. All patients, except one, treated with chemotherapy only had normal thyroid function. However, five patients who received additional radiation to the thyroid either had abnormal levels of TSH or free T4, or used thyroid hormones. CONCLUSIONS: Lean body mass was normal in all patients; thyroid function was normal in all but one patient. The use of MOPP leads to decreased height and increased body mass index in men and decreased BMD-TB in women.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Densidad Ósea , Desarrollo Infantil/fisiología , Enfermedad de Hodgkin/tratamiento farmacológico , Enfermedad de Hodgkin/fisiopatología , Sobrevivientes , Glándula Tiroides/fisiología , Adolescente , Adulto , Algoritmos , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Bleomicina/administración & dosificación , Bleomicina/farmacología , Composición Corporal/efectos de los fármacos , Composición Corporal/fisiología , Densidad Ósea/efectos de los fármacos , Niño , Desarrollo Infantil/efectos de los fármacos , Estudios Transversales , Doxorrubicina/administración & dosificación , Doxorrubicina/farmacología , Femenino , Estudios de Seguimiento , Enfermedad de Hodgkin/rehabilitación , Humanos , Masculino , Mecloretamina/administración & dosificación , Mecloretamina/farmacología , Prednisona/administración & dosificación , Prednisona/farmacología , Procarbazina/administración & dosificación , Procarbazina/farmacología , Estudios Retrospectivos , Glándula Tiroides/efectos de los fármacos , Vinblastina/administración & dosificación , Vinblastina/farmacología , Vincristina/administración & dosificación , Vincristina/farmacología , Adulto JovenRESUMEN
BACKGROUND: Although cancer survivorship is increasing with improved diagnosis and treatments, few studies have explored employment changes and the factors related to this change among cancer survivors. Therefore, we aim to explore the prevalence of employment problems in long-term cancer survivors. In addition, we explored what patient or tumour characteristics predicted employment changes. METHODS: All 1893 long-term survivors of prostate cancer, endometrial cancer, non-Hodgkin's lymphoma, and Hodgkin's lymphoma diagnosed between 1989 and 1998 in the area of the Comprehensive Cancer Centre South, The Netherlands were included in a population-based cross-sectional survey. RESULTS: Response rate was 80% (n=1511). After excluding survivors without a job before diagnosis, 403 survivors remained; 197 (49%) experienced no changes in their work situation following cancer diagnosis, 69 (17%) were working fewer hours, and 137 (34%) stopped working or retired. A medium educational level was significant in reducing the risk of work changes. Being older, having more than one comorbid condition, being treated with chemotherapy, and disease progression were significant independent predictors of work changes after cancer. Experiencing work changes was associated with lower physical functioning but positively associated with social well-being. DISCUSSION: Long-term cancer survivors experience work changes after diagnosis and treatment, and clinical factors significantly predicted work change after cancer. As such, our study underscores the importance of rehabilitation programs in improving the return to work after cancer.
Asunto(s)
Neoplasias/psicología , Neoplasias/rehabilitación , Rehabilitación Vocacional , Sobrevivientes/psicología , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Comorbilidad , Estudios Transversales , Progresión de la Enfermedad , Escolaridad , Neoplasias Endometriales/psicología , Neoplasias Endometriales/rehabilitación , Femenino , Encuestas Epidemiológicas , Enfermedad de Hodgkin/psicología , Enfermedad de Hodgkin/rehabilitación , Humanos , Linfoma no Hodgkin/psicología , Linfoma no Hodgkin/rehabilitación , Masculino , Persona de Mediana Edad , Países Bajos , Neoplasias de la Próstata/psicología , Neoplasias de la Próstata/rehabilitación , Calidad de Vida/psicología , Jubilación , Factores de Riesgo , Tolerancia al Trabajo ProgramadoRESUMEN
Hodgkin lymphoma (HL) is a disease that typically strikes children and young adults, with more than 80% of those affected being cured. Consequently, HL survivors can live for decades with the persistent and late-emerging effects of the disease and its treatment. The focus of this article is the long-term medical management of HL survivors, specifically those who are 5 years or more off therapy without evidence of relapse, when the focus of follow-up care shifts from detecting relapse to minimizing the morbidity associated with the late effects of treatment.
Asunto(s)
Enfermedad de Hodgkin/rehabilitación , Sobrevivientes , Cuidados Posteriores/métodos , Enfermedades Cardiovasculares/diagnóstico , Enfermedad de Hodgkin/terapia , Humanos , Neoplasias Primarias Secundarias/diagnóstico , Guías de Práctica Clínica como AsuntoRESUMEN
Tumour-related fatigue, which occurs in almost all tumour patients under therapy--very often even years after a successful therapy--has a considerable impact not only on the quality of life, but apparently also on the course and outcome of treatment. There is little known about where cancer fatigue syndrome comes from. Medical research is required particularly for the continuous states of tiredness persisting for years. The questionnaires currently in use permit an accurate evaluation of the existence and the course of tumour-related fatigue. The treatment of the cancer fatigue syndrome includes the correction of underlying metabolic disorders as well as--even more importantly--physical training and psycho-oncological measures in order to better cope with the disease. Many questions, however, are left open, for instance the impact of cancer fatigue syndrome on disability pensions of tumour patients. The German Fatigue Society (DfaG) was therefore founded in March 2002 in order to find out the correlations between these questions and the cancer fatigue syndrome.
Asunto(s)
Fatiga/etiología , Neoplasias/complicaciones , Terapia Combinada , Consejo , Ejercicio Físico , Fatiga/rehabilitación , Enfermedad de Hodgkin/complicaciones , Enfermedad de Hodgkin/rehabilitación , Humanos , Neoplasias/rehabilitación , Rehabilitación Vocacional , SíndromeRESUMEN
Post-traumatic stress disorder (PTSD) has not been examined systematically in long-term survivors of lymphoma. In this study, PTSD and health related quality of life (HRQoL) were assessed in 44 patients with Hodgkin's disease (n = 8) or non-Hodgkin's lymphoma (n = 36). Forty-four individuals who had experienced traumatic events as defined by the Diagnostic and Statistical Manual-IV (DSM-IV) as possible triggers for PTSD served as controls. The study participants were administered two questionnaires-the PTSD inventory scale and the Short Form-36 (SF-36) HRQoL instrument measuring physical and mental HRQoL. Full PTSD was defined as meeting the DSM-IV criteria for the diagnosis in all three symptom groups measured on the PTSD inventory scale-intrusion, avoidance and hyper-arousal and partial PTSD as meeting the diagnostic criteria in two of the symptom groups. There was a significant increase in the hyper-arousal scale in the lymphoma survivor group (F 5, P < 0.05). Overall, full or partial PTSD was found in 14 lymphoma survivors (32%) and in 11 individuals (25%) in the control group (difference not significant). Survivors whose disease had started at an earlier age suffered significantly more intensive intrusion and avoidance symptoms. The lymphoma survivor group had a significantly lower physical HRQoL than the control group independent of PTSD symptoms. In both groups, the presence of PTSD symptoms correlated with a lower HRQoL. These results suggest that lymphoma is a trauma similar to other more accepted definitions of trauma which can lead to PTSD, and is associated with more severe hyper-arousal symptoms. Psychological interventions in the early stages of treatment or follow-up may help reduce the morbidity from PTSD and improve quality of life.
Asunto(s)
Adaptación Psicológica , Enfermedad de Hodgkin/psicología , Linfoma no Hodgkin/psicología , Calidad de Vida , Trastornos por Estrés Postraumático/etiología , Sobrevivientes/psicología , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Femenino , Enfermedad de Hodgkin/rehabilitación , Humanos , Israel/epidemiología , Linfoma no Hodgkin/rehabilitación , Masculino , Persona de Mediana Edad , Trastornos por Estrés Postraumático/epidemiología , Trastornos por Estrés Postraumático/psicología , Encuestas y Cuestionarios , Factores de TiempoAsunto(s)
Enfermedades Bronquiales/complicaciones , Intubación Intratraqueal/instrumentación , Enfermedades de la Tráquea/complicaciones , Adulto , Enfermedades Bronquiales/diagnóstico por imagen , Enfermedades Bronquiales/etiología , Enfermedad de Hodgkin/complicaciones , Enfermedad de Hodgkin/diagnóstico por imagen , Enfermedad de Hodgkin/rehabilitación , Humanos , Masculino , Neoplasias del Mediastino/complicaciones , Neoplasias del Mediastino/diagnóstico por imagen , Neoplasias del Mediastino/terapia , Tomografía Computarizada por Rayos X , Enfermedades de la Tráquea/diagnóstico por imagen , Enfermedades de la Tráquea/etiologíaRESUMEN
Preliminary evidence indicates that physical exercise may be an effective strategy for the rehabilitation of cancer patients following high dose chemotherapy (HDC) and bone marrow transplantation (BMT), but the focus of this research has been on physical fitness and medical outcomes. In the present study, we employed a prospective design to examine the relationship between physical exercise and various quality of life (QOL) indices in 25 BMT patients. Participants completed weekly self-administered questionnaires upon being admitted to hospital, and monitored the frequency and duration of their exercise during hospitalization. Statistical analyses indicated that exercise during hospitalization was significantly correlated with almost all QOL indices, including physical well-being, psychological well-being, depression, anxiety and days hospitalized. Moreover, only some of the correlations were attenuated after controlling for relevant demographic and medical variables. It was concluded that physical exercise may be related to QOL in BMT patients, but that experimental research is needed before any definitive conclusions can be drawn.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Ejercicio Físico , Trasplante de Células Madre Hematopoyéticas , Neoplasias/rehabilitación , Calidad de Vida , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de la Mama/psicología , Neoplasias de la Mama/rehabilitación , Terapia Combinada , Relación Dosis-Respuesta a Droga , Femenino , Trasplante de Células Madre Hematopoyéticas/psicología , Enfermedad de Hodgkin/psicología , Enfermedad de Hodgkin/rehabilitación , Humanos , Linfoma no Hodgkin/psicología , Linfoma no Hodgkin/rehabilitación , Masculino , Persona de Mediana Edad , Mieloma Múltiple/psicología , Mieloma Múltiple/rehabilitación , Neoplasias/psicología , Aptitud Física , Estudios Prospectivos , Rol del EnfermoRESUMEN
AIM: Investigation of the condition of the liver, gastrointestinal tract, heart in patients at the stage of clinicohematological remission after treatment for hemoblastosis (acute leukemia, Hodgkin's disease, non-Hodgkin's lymphoma). RESULTS: Marked functional-morphological changes were found: endomyocardial fibrosis, cardiopathy, pulmonary hypertension, chronic atrophic gastritis, colon lesions, dysbacteriosis, viral or drug-induced hepatitis. CONCLUSION: The above affections have developed because of the treatment: chemotherapy, radiotherapy, hemotransfusions, antibacterial drugs. They deteriorate life quality and require a special system of rehabilitation measures.
Asunto(s)
Enfermedad de Hodgkin/complicaciones , Leucemia/complicaciones , Linfoma no Hodgkin/complicaciones , Insuficiencia Multiorgánica/etiología , Enfermedad Aguda , Adulto , Estudios de Seguimiento , Enfermedad de Hodgkin/rehabilitación , Enfermedad de Hodgkin/terapia , Humanos , Leucemia/rehabilitación , Leucemia/terapia , Linfoma no Hodgkin/rehabilitación , Linfoma no Hodgkin/terapia , Persona de Mediana Edad , Calidad de Vida , Factores de TiempoRESUMEN
The great majority of patients with Hodgkin's disease (HD) are successfully treated. However, several reports on treatment sequela have been published. The object of this study was to examine the quality of life (QOL) among survivors of HD focusing on gender and treatment modalities. All patients treated for HD at our oncological unit between 1985 and 1993 (n = 55) were registered. In December 1994, 49 survivors were mailed a questionnaire consisting of the EORTC QLQ-C30. Forty-two patients responded (86%). They reported a low frequency of symptoms and a high level of functioning. There was a significant correlation between mantle field irradiation and dyspnoea (p = 0.023). Females reported a significantly superior global quality of life (p = 0.016) and a lower fatigue score (p = 0.040) compared to males. Almost half of the patients reported financial difficulties. To improve QOL among survivors of HD, groups at risk have to be identified. Patients treated with mantle field irradiation and males seems to be at a higher risk. Should the treatment of HD be altered towards less radiotherapy and more chemotherapy?
Asunto(s)
Enfermedad de Hodgkin/psicología , Calidad de Vida , Sobrevida/psicología , Actividades Cotidianas/psicología , Adaptación Psicológica , Adulto , Terapia Combinada , Femenino , Enfermedad de Hodgkin/rehabilitación , Humanos , Pulmón/efectos de la radiación , Masculino , Determinación de la Personalidad , Traumatismos por Radiación/psicología , Estudios Retrospectivos , Rol del EnfermoRESUMEN
The high efficiency of treatment of lymphogranulomatosis in children by the currently available protocols determines the necessity of assessing them in terms of the quality of further life. The opportunity of creating a life and having the offspring, that of getting education and a profession are one of the main characteristics of the quality of life. The data on the reproductive function and social adaptation of 443 children receiving multimodality treatment for lymphogranulomatosis by 3 protocols (from 1976, 1978, and 1987). Two hundred and fifty eight individuals were 18 years old or more. Sixty four former patients have 88 children who are all healthy. The treatment performed in childhood intensively, which yielded a complete effect, exerts no substantial impact on the formation and performance of their reproductive function. The former patients have a high intellect, without limitations in getting professions, and they are easily adaptable to the changing social conditions.
Asunto(s)
Enfermedad de Hodgkin/psicología , Enfermedad de Hodgkin/terapia , Calidad de Vida , Ajuste Social , Adolescente , Niño , Preescolar , Terapia Combinada , Femenino , Enfermedad de Hodgkin/rehabilitación , Humanos , Lactante , Masculino , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
Se revisaron 37 historias médicas con diagnóstico de linfoma no Hodgkin en el período comprendido entre enero de 1989 y diciembre de 1993. Seis pacientes (16.2 por ciento) presentaron localización primaria de dicha enfermedad a nivel gástrico. La edad media fue de 57.5 años, con igual distribución por sexo. La pérdida de peso y la epigastralgia fueron los síntomas más frecuentes con un 83.3 y 66.6 por ciento respectivamente. Sólo en dos pacientes (33.3 por ciento) el examen físico demostró adenomegalias y/o hepatoesplenomegalia. La biopsia gástrica por endoscopia del tracto digestivo superior fue el método diagnóstico de elección, con una sensibilidad del 90 por ciento y una especificidad del 80 por ciento. Dos pacientes (33.3 por ciento) se clasificaron según el sistema de Ann Arbor en estadio I; dos en estadio II, 1 (16.6 por ciento) en estadio III y 1 en estadio IV. El patrón histiocítico difuso se observó en todos los estudios histopatológicos. Los 6 pacientes se traron con radioterapia, quimioterapia o ambos inicialmente. Uno de ellos presentó intolerancia a la quimioterapia, por lo que fue sometido a radioterapia. Tres tuvieron reactivación y uno persistencia de la enfermedad. Tres pacientes no cumplieron el tratamiento (no regresaron a los controles clínicos) por causas desconocidas. De los tres pacientes en lo que se reactivó la neoplasia, uno fue sometido a cirugía y los otros dos a quimioterapia. Actualmente se encuentran libres de enfermedad con un seguimiento promedio de 39,3 meses